| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/23/1999 | EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/23/1999 | EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 06/23/1999 | EP0923382A1 Compositions of plant carbohydrates as dietary supplements |
| 06/23/1999 | EP0923377A1 Therapeutic uses for an aminosterol compound |
| 06/23/1999 | EP0639186B1 Taxol derivatives |
| 06/23/1999 | CN1220658A Galcium receptor-active compound |
| 06/23/1999 | CN1220656A Novel trienoic retinoid compounds and method |
| 06/23/1999 | CN1220600A Tetrahydrolipstatin-containing compositions |
| 06/23/1999 | CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof |
| 06/23/1999 | CN1043763C Tropane-aldoxine derivatives and preparation process and use thereof |
| 06/22/1999 | US5914347 By adding to a hydroxyalkyl cellulose, evaporating the solution or dispersion to dryness under an inert atmosphere to prepare a powder; imparts oxidation resistance |
| 06/22/1999 | US5914329 Dimesylate salts of neuropeptide Y ligands |
| 06/22/1999 | US5914323 Treating hypercalcemia of malignancy, metastatic bone disease and/or metabolic bone disease by administering an isotonic aqueous alendronate solution with a buffer to maintain the ph in the range 4 to 8 to prevent precipitation |
| 06/22/1999 | US5914130 In specifies rahges as a swallowable pills, caplets, tabletsor capsules to reduce body acid |
| 06/22/1999 | US5914106 Interleukin-6 receptor agonists |
| 06/22/1999 | CA2151674C Methods of administering crf antagonists |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029685A1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2-[(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt |
| 06/17/1999 | WO1999029673A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 06/17/1999 | WO1999029672A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 06/17/1999 | WO1999029669A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 06/17/1999 | WO1999029662A2 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 06/17/1999 | WO1999029336A1 Glp-1 formulations |
| 06/17/1999 | WO1999029333A1 Compositions and methods for weight reduction |
| 06/17/1999 | WO1999029332A1 Compositions for weight reduction |
| 06/17/1999 | WO1999029324A1 Preventives/remedies for diabetes |
| 06/17/1999 | WO1999029321A1 Inhibition of membrane-associated viral replication |
| 06/17/1999 | WO1999029317A1 Methods and compositions for treating diabetes |
| 06/17/1999 | WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/17/1999 | WO1999029314A1 Novel salts of metformin and method |
| 06/17/1999 | WO1999029308A2 Method for combating obesity |
| 06/17/1999 | WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 06/17/1999 | DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation |
| 06/17/1999 | DE19754795A1 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313626A1 Methods and compositions for treating diabetes |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312987A1 Selective .beta.3 adrenergic agonists |
| 06/17/1999 | CA2312965A1 (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chlorophenyl|-1h-pyrazol-4-yl|-2-¬(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl|-prop-2-enoic acid monoargininyl salt |
| 06/17/1999 | CA2312849A1 Selective .beta.3 adrenergic agonists |
| 06/17/1999 | CA2312716A1 Medicament for prevention and treatment of diabetes |
| 06/17/1999 | CA2312423A1 Inhibition of membrane-associated viral replication |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2312190A1 Glp-1 formulations |
| 06/17/1999 | CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them |
| 06/16/1999 | EP0921820A1 Gene therapy for obesity |
| 06/16/1999 | EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921798A1 Novel treatment of leptine resistance |
| 06/16/1999 | EP0921796A1 Tetrahydrolipstatin containing compositions |
| 06/16/1999 | EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 06/16/1999 | EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 06/16/1999 | EP0553218B1 Indole derivatives |
| 06/16/1999 | CN1219928A Novel vitamin D analogues |
| 06/16/1999 | CN1219873A Remedy or preventive medicine for hyperlipemia |
| 06/16/1999 | CN1043643C Cyclohexan derivative and its use for preparing medicine |
| 06/16/1999 | CN1043610C Novel treatment agent |
| 06/16/1999 | CN1043608C Improvements in or relating to benzothiophenes |
| 06/15/1999 | US5912325 A polypeptide which codes for an epitope of an animal growth hormone; animal growth enhancer |
| 06/15/1999 | US5912262 Heterocyclic compounds |
| 06/15/1999 | US5912005 Methods of use of uncoated gel particles |
| 06/15/1999 | US5911993 For non-insulin dependent diabetes to lower blood sugar; administering extracts from plants of family crassulaceae, genus sinocressula berger; breaking cell walls of crushed leaves, filtration, form powder from concentrated filtrate |
| 06/15/1999 | US5911984 Disorders associated with fatty acid metabolism. |
| 06/15/1999 | CA2136821C Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 06/10/1999 | WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51 |
| 06/10/1999 | WO1999027952A1 Anti-hypoxic and anti-ischemic drug |
| 06/10/1999 | WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 06/10/1999 | WO1999007737A3 Lsr receptor, cloning and uses |
| 06/10/1999 | WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
| 06/10/1999 | DE19754082A1 Methode zur Bekämpfung der Fettleibigkeit Method to combat obesity |
| 06/09/1999 | EP0921120A1 Selective beta 3 adrenergic agonists |
| 06/09/1999 | EP0920870A1 Flavanone-containing composition |
| 06/09/1999 | EP0920865A1 Pharmaceutical compositions containing Norastemizole |
| 06/09/1999 | EP0920864A1 Combination therapy including a specific beta-3 agonist and an anorectic agent |
| 06/09/1999 | EP0920863A1 2-Aryl-3-aroylbenzo(b)thiophenes useful for the treatment of estrogen deprivation syndrome |
| 06/09/1999 | EP0920862A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome |
| 06/09/1999 | EP0920632A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 06/09/1999 | EP0920528A1 Synthetic protein folding catalysis |
| 06/09/1999 | EP0920503A2 A novel human leptin receptor gene-related protein |
| 06/09/1999 | EP0920446A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/09/1999 | EP0920429A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 06/09/1999 | EP0877563A4 Food and vitamin preparations containing the natural isomer of reduced folates |
| 06/09/1999 | EP0799035A4 Emulsion suitable for administering a sphingolipid and use thereof |
| 06/09/1999 | EP0775103B1 Retinoic acid x-receptor ligands |
| 06/09/1999 | EP0751932B1 Vitamin-d amide derivatives |
| 06/09/1999 | EP0647636B1 Benzothiazole compound, process for producing the same, and use thereof |
| 06/09/1999 | EP0615549B1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
| 06/09/1999 | EP0614456B1 1alpha,24(s)-dihydroxy vitamin d2, its formation and use |
| 06/09/1999 | EP0578723B1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS |
| 06/09/1999 | CN1219128A Method of increasing nitric oxide synthesis |
| 06/09/1999 | CN1218808A Dithio-heterocyclic-pentylene acetamide derivatives |
| 06/09/1999 | CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition |
| 06/08/1999 | US5910592 Substituted thiazolidinedione derivatives |
| 06/08/1999 | US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis |
| 06/08/1999 | US5910494 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 06/08/1999 | US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body |
| 06/08/1999 | US5910435 Exposing protein with non-native disulfide bonds to non-protein compound with pka less than 8 and eo greater than -0.25 volts; for proper conformation of heterologous eukaryotic proteins from prokaryotic hosts |
| 06/08/1999 | US5910427 Protein derivatives formed by replacement, substitution, or chemical modification of amino acids 57 and/or 60 having increased activity; for immunosuppressives/allergy treatments |